Affordable Access

PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.

Authors
Type
Published Article
Journal
Diabetes Care
0149-5992
Publisher
American Diabetes Association
Publication Date
Volume
28
Issue
9
Pages
2093–2099
Identifiers
PMID: 16123472
Source
Medline
License
Unknown

Abstract

Similar good glycemic control can be maintained for 2 years with either treatment regimen, but nateglinide/metformin may represent a safer approach to initial combination therapy.

Statistics

Seen <100 times